The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer
Authors:
Open Access
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 50 (5) , 434-446
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Role of 18F-FDG PET/CT in Detecting Recurrent Gallbladder CarcinomaClinical Nuclear Medicine, 2012
- Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and HumansJournal of Nuclear Medicine, 2012
- Differential Expression of Metabolic Genes in Tumor and Stromal Components of Primary and Metastatic Loci in Pancreatic AdenocarcinomaPLOS ONE, 2012
- Risk Stratification of Gallbladder Polyps (1–2 cm) for Surgical Intervention with 18F-FDG PET/CTJournal of Nuclear Medicine, 2012
- 18F-FDG PET/CT influences management in patients with known or suspected pancreatic cancerInternal Medicine Journal, 2010
- A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Diagnosis and Staging of Pancreatic CancerAnnals of Surgery, 2009
- The role of PET-CT in patients with incidental gallbladder cancerHPB, 2009
- Contrast-Enhanced 18F-FDG PET/CT: 1-Stop-Shop Imaging for Assessing the Resectability of Pancreatic CancerJournal of Nuclear Medicine, 2008
- 18F-fluorodeoxyglucose Positron Emission Tomography Influences Management Decisions in Patients with Biliary CancerJournal of the American College of Surgeons, 2008
- Application of modern imaging methods in diagnosis of gallbladder cancerJournal of Surgical Oncology, 2006